Corona Remedies Ltd

₹ 1,463 1.07%

08 Jan - close price

Company website BSE: 544644 NSE: CORONA

About

[ edit about ]

[ add key points ]

Website BSE NSE

Market Cap ₹ 8,948 Cr.
Current Price ₹ 1,463
High / Low ₹ 1,524 / 1,337
Stock P/E 56.2
Book Value ₹
Dividend Yield 0.00 %
ROCE 31.5 %
ROE 27.6 %
Face Value ₹ 10.0

Add ratio to table

Edit ratios

Pros

Company has reduced debt.
Company has been maintaining a healthy dividend payout of 25.0%

Cons

Promoter holding has decreased over last quarter: -3.50%

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals

Part of BSE IPO

Edit Columns

Loading peers table ...

Detailed Comparison with:

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

	Sep 2024	Jun 2025	Sep 2025
	314	347	361
	247	277	283
Operating Profit	67	70	78
OPM %	21%	20%	22%
	2	2	2
Interest	3	2	2
Depreciation	9	9	9
Profit before tax	57	61	70
Tax %	25%	24%	25%
	43	46	52
EPS in Rs	7.03	7.55	8.55
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2023	Mar 2024	Mar 2025
	884	1,014	1,196
	756	859	956
Operating Profit	128	156	241
OPM %	14%	15%	20%
	7	5	6
Interest	4	14	11
Depreciation	20	28	37
Profit before tax	111	118	199
Tax %	23%	24%	25%
	85	90	149
EPS in Rs	13.89	14.80	24.43
Dividend Payout %	20%	25%	30%

Compounded Sales Growth
10 Years:	%
5 Years:	%
3 Years:	%
TTM:	18%

Compounded Profit Growth
10 Years:	%
5 Years:	%
3 Years:	%
TTM:	64%

Stock Price CAGR
10 Years:	%
5 Years:	%
3 Years:	%
1 Year:	%

Return on Equity
10 Years:	%
5 Years:	%
3 Years:	%
Last Year:	28%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2023	Mar 2024	Mar 2025	Sep 2025
Equity Capital	61	61	61	61
Reserves	347	419	545	598
	28	159	86	63
	159	191	237	254
Total Liabilities	595	831	930	977
	185	384	370	394
CWIP	65	121	186	205
Investments	32	26	26	0
	314	301	348	378
Total Assets	595	831	930	977

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2023	Mar 2024	Mar 2025
	103	157	190
	-50	-267	-84
	-45	99	-107
Net Cash Flow	8	-11	0

Ratios

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2023	Mar 2024	Mar 2025
Debtor Days	36	36	36
Inventory Days	182	158	200
Days Payable	163	184	221
Cash Conversion Cycle	55	10	14
Working Capital Days	30	-2	9
ROCE %		25%	32%

Shareholding Pattern

Numbers in percentages

6 Recently

	Dec 2025
	69.00%
	1.04%
	3.65%
	26.32%
No. of Shareholders	1,59,545

	Dec 2025
	69.00%
	1.04%
	3.65%
	26.32%
No. of Shareholders	1,59,545

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

All

Annual reports

No data available.

DRHP

Concalls

Jan 2026

Transcript

AI Summary
PPT REC